Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.

Kimberly P. Dunsmore,Stuart S. Winter,Meenakshi Devidas,Brent L. Wood,Natia Esiashvili,Zhiguo Chen,Nancy Eisenberg,Nikki Briegel,Robert J. Hayashi,Julie M. Gastier-Foster,Andrew J. Carroll,Nyla A. Heerema,Barbara L. Asselin,Karen R. Rabin,Patrick A. Zweidler-McKay,Elizabeth A. Raetz,Mignon L. Loh,Kirk R. Schultz,Naomi J. Winick,William L. Carroll,Stephen P. Hunger

Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.

2020

PURPOSENelarabine is effective in inducing remission in patients with relapsed and refractory T-cell acute lymphoblastic leukemia (T-ALL) but has not been fully evaluated in those with newly diagno...

Keywords:

in patient
newly diagnosed
Medicine
MEDLINE
Internal medicine
Lymphoblastic Leukemia
Refractory
Oncology
Randomized controlled trial
T cell
Nelarabine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations